COMBINATION THERAPIES FOR TREATMENT OF HCV

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160206645A1
SERIAL NO

15001705

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure is directed to the use of a combination of simeprevir, daclatasvir, and sofosbuvir for the treatment of hepatitis C virus infection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JANSSEN RESEARCH & DEVELOPMENT LLC920 US ROUTE 202 RARITAN NJ 08869

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beets, Greta Irene A Beerse, BE 1 0
Beumont, Maria Gloria Bievres, FR 11 19
Hughes, Eric A Skillman, US 1 0
Jacquemyn, Bert Beerse, BE 4 10
Kakuda, Thomas Naoki South San Francisco, US 6 3
Luo, Donghan Titusville, US 1 0
Mahadevan, Sivi Ravels, BE 6 3
Noviello, Stephanie Bridgewater, US 1 0
Picchio, Gaston Rafael San Diego, US 11 20
Van, Remoortere Peter Josef Maria Princeton, US 2 2
Vandevoorde, Ann Tamara Beerse, BE 1 0
Vijgen, Leen Roger Itta Beerse, BE 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation